August 8, 2024
Seer Reports Second Quarter 2024 Financial Results
July 18, 2024
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
June 11, 2024
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
June 2, 2024
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
May 8, 2024
Seer Reports First Quarter 2024 Financial Results
May 8, 2024
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
April 23, 2024
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
February 29, 2024
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
February 21, 2024
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
February 6, 2024
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
Pagination